CLASS ACTION INVESTOR ALERTS: Bragar Eagel & Squire, P.C.

robot
Abstract generation in progress

Bragar Eagel & Squire, P.C. has issued investor alerts reminding shareholders of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) about pending class action lawsuits. The lawsuits allege that both companies made false and misleading statements regarding the Phase III Orbit and Cosmic Studies for setrusumab, which failed to meet primary endpoints for reducing annualized fracture rates, leading to significant stock price drops. Investors are encouraged to contact the firm to discuss serving as lead plaintiff.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments